Concepedia

Martin J. Slater

MJ

Statistics

Publications

30

Citations

1.5K

H-Index

21

Active since

1981

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Wellcome Trust

GlaxoSmithKline (United States)

Cresset (United Kingdom)

Age UK

Martin J. Slater is an author at GlaxoSmithKline (United Kingdom) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

1981–2025

30

Publications

30

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase

Jason D. Oliver, Graham E. M. Sibley, Nicola Beckmann et al. · Proceedings of the National Academy of Sciences · 2016 · 282 citations · Full text

, , +17

The Design and Application of Target-Focused Compound Libraries

C John Harris, R. D. Hill, David W. Sheppard et al. · Combinatorial Chemistry & High Throughput Screening · 2011 · 130 citations · Full text

, , +16

Stereospecific dicobalt octacarbonyl mediated enyne cyclization for the synthesis of the cytotoxic sesquiterpene (.+-.)-quadrone

Philip Magnus, Lawrence M. Principe, Martin J. Slater · The Journal of Organic Chemistry · 1987 · 122 citations

, , +10

Phenylethylthiazolylthiourea (PETT) Non-nucleoside Inhibitors of HIV-1 and HIV-2 Reverse Transcriptases

Jingshan Ren, Jonathan M. Diprose, Jonathan Warren et al. · Journal of Biological Chemistry · 2000 · 115 citations · Full text

, , +17

Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate

Martin J. Slater, Elizabeth M. Amphlett, David Andrews et al. · Journal of Medicinal Chemistry · 2007 · 90 citations

, , +16

1–5 of 30